The Northstar AI Results Explorer can be incorporated directly into existing clinical workflows. Within the platform, radiologists can not only view AI-produced images and reports, but also assess individual measurements, markings and other findings generated by the technology, examining the AI’s decision-making process to determine and fine-tune the data’s accuracy and thus accept or reject the algorithm’s findings.
The FDA gave the platform a “first-of-kind” determination, labeling it a Class I medical device and therefore granting it full commercial availability.
Editor’s note: This article was updated June 25 at 9:00 a.m. to clarify the FDA’s determination.
More articles about AI:
Updated White House AI policy prioritizes public-private collaboration
Philips updates AI-enabled cardiac ultrasound platform to make it faster, easier to use
AI-guided robotic device replaces endoscopy in diagnosing colon cancer
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
